NCT01871766 2025-12-17Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified ChemotherapySt. Jude Children's Research HospitalPhase 2 Active not recruiting115 enrolled
NCT01505569 2024-02-26Auto Transplant for High Risk or Relapsed Solid or CNS TumorsMasonic Cancer Center, University of MinnesotaPhase NA Completed44 enrolled
NCT00788125 2023-07-14Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsCity of Hope Medical CenterPhase 1/2 Terminated7 enrolled 9 charts
NCT00003657 2017-01-20High-dose ICE With AmifostineDana-Farber Cancer InstitutePhase 2 Completed24 enrolled
NCT00613223 2013-02-20Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant GliomasDuke UniversityPhase 1 Completed49 enrolled